Coronavirus live news: Rio de Janeiro to halt vaccinations due to lack of shots; UK variant hits New Zealand
‘The new doses did not arrive,’ says Rio’s mayor; Australia suspends quarantine-free travel with New Zealand
- Israel battles Covid misinformation as vaccination drive slows
- Risk of global food shortages due to Covid has increased, says UN envoy
- Lack of Covid data may leave African countries behind in vaccine rush
- Pakistan to allow private firms to import coronavirus vaccines
- See all our coronavirus coverage
The number of new daily Covid-19 deaths in Portugal fell to its lowest level in around six weeks on Monday, with infections also declining, adding to evidence that an alarming post-Christmas surge in the coronavirus pandemic is slowing.
Reuters reports:
The good news came hours after grim data showing the once-booming tourism sector suffered its worst results since the mid-1980s last year as the pandemic and subsequent lockdowns worldwide grounded flights and kept visitors away.
There were 90 more deaths from Covid-19 reported on Monday, the first daily toll below 100 since early January, while the tally of new infections was down to 1,303, the lowest level seen since late December.
The World Health Organisation (WHO) has approved the Oxford/AstraZeneca coronavirus jab for emergency use, meaning the vaccine can be rolled out globally and participate in the Covax programme that aims to bring vaccines to poorer countries.
A WHO statement said it had approved the vaccine as produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.
The listing by the UN health agency comes days after a WHO panel provided interim recommendations on the vaccine, saying two doses with an interval of around 8 to 12 weeks must be given to all adults, and can be used in countries with the South African variant of the coronavirus as well.
The AstraZeneca/Oxford shot has been hailed because it is cheaper and easier to distribute than some rivals, including Pfizer/BioNTech’s , which was listed for emergency use by the WHO late in December.
Read the original article at The Guardian